Gut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease

Area of Science:

• Gastroenterology
• Microbiome Research
• Computational Biology

Background:

• Developing reliable microbiome-based biomarkers for pediatric inflammatory bowel disease (PIBD) presents significant challenges.
• Gut microbiome alterations are implicated in the pathogenesis and progression of inflammatory bowel disease.

Purpose of the Study:

• To evaluate the diagnostic and prognostic potential of the gut microbiome in pediatric inflammatory bowel disease.
• To identify microbial signatures associated with active PIBD and remission.
• To develop predictive models for PIBD remission using machine learning.

Main Methods:

• Case-control study of a Korean PIBD cohort (24 patients, 43 controls).
• Cross-cohort analysis integrating seven PIBD cohorts (n=1,670) using differential abundance meta-analysis.
• Training and testing of machine learning models (ensemble model) on baseline bacterial composition.

Main Results:

• Significant shifts in gut microbial diversity and composition were observed in active PIBD patients compared to controls.
• Microbial profiles recovered to remission levels.
• An ensemble machine learning model effectively predicted future PIBD remission based on baseline microbial data.

Conclusions:

• The gut microbiome exhibits diagnostic and prognostic potential in pediatric inflammatory bowel disease.
• Microbial markers can distinguish between active disease and remission.
• Machine learning approaches utilizing microbiome data can guide precision therapy for PIBD.